RPHM Insider Trading Activity and SEC Form 4 Filings
RPHM insider trading summary
No open-market insider purchases or sales of Reneo Pharmaceuticals, Inc. (RPHM) have been reported on SEC Form 4 in the past 12 months.
Latest RPHM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 25, 2024 | Braden Michael Leonard | Insider | Buy | $103K (68,746 @ $1.50) |
| Sep 24, 2024 | Braden Michael Leonard | Insider | Buy | $42K (29,600 @ $1.41) |
| Sep 18, 2024 | Braden Michael Leonard | Insider | Buy | $1K (806 @ $1.40) |
| Sep 17, 2024 | Braden Michael Leonard | Insider | Buy | $75K (55,300 @ $1.36) |
| Sep 16, 2024 | Braden Michael Leonard | Insider | Buy | $237K (172,747 @ $1.37) |
| Sep 13, 2024 | Braden Michael Leonard | Insider | Buy | $197K (150,000 @ $1.31) |
| Sep 12, 2024 | Braden Michael Leonard | Insider | Buy | $51K (36,176 @ $1.40) |
| Aug 14, 2024 | Braden Michael Leonard | Insider | Buy | $142K (100,487 @ $1.41) |
| Aug 13, 2024 | Braden Michael Leonard | Insider | Buy | $239K (171,339 @ $1.39) |
| May 14, 2024 | Braden Michael Leonard | Insider | Buy | $124K (79,281 @ $1.56) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.